OTCPK:BDAB.F

Stock Analysis Report

Executive Summary

Boule Diagnostics AB (publ), a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics.

Snowflake

Fundamentals

Flawless balance sheet with solid track record.

Share Price & News

How has Boule Diagnostics's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

BDAB.F

1.7%

US Medical Equipment

2.3%

US Market


1 Year Return

n/a

BDAB.F

10.1%

US Medical Equipment

5.6%

US Market


Shareholder returns

BDAB.FIndustryMarket
7 Day0%1.7%2.3%
30 Day0%-1.7%-1.0%
90 Day0%-1.7%-0.7%
1 Yearn/a11.0%10.1%7.9%5.6%
3 Yearn/a70.4%65.2%45.6%36.3%
5 Yearn/a128.5%103.2%65.8%47.6%

Price Volatility Vs. Market

How volatile is Boule Diagnostics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Boule Diagnostics undervalued compared to its fair value and its price relative to the market?

19.6%

Undervalued compared to fair value


Share Price vs. Fair Value

Information is not available.

Information is not available.


Price To Earnings Ratio

Information is not available.

Information is not available.


Price to Earnings Growth Ratio

Information is not available.


Price to Book Ratio

Information is not available.


Next Steps

Future Growth

How is Boule Diagnostics forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

16.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Information is not available.

Information is not available.

High Growth Earnings: BDAB.F's earnings are forecast to grow, but not significantly.

Information is not available.

Information is not available.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has Boule Diagnostics performed over the past 5 years?

54.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Information is not available.

Information is not available.

Information is not available.


Return on Equity

Information is not available.


Return on Assets

Information is not available.


Return on Capital Employed

Information is not available.


Next Steps

Financial Health

How is Boule Diagnostics's financial position?


Financial Position Analysis

Information is not available.

Information is not available.


Debt to Equity History and Analysis

Information is not available.

Information is not available.

Information is not available.

Information is not available.


Balance Sheet

Information is not available.

Information is not available.


Next Steps

Dividend

What is Boule Diagnostics's current dividend yield, its reliability and sustainability?

0.90%

Current Dividend Yield


Dividend Yield vs Market

company0.9%marketbottom25%1.5%markettop25%3.8%industryaverage1.2%forecastin3Years1.8%

Current dividend yield vs market & industry


Stability and Growth of Payments

Information is not available.

Information is not available.

Stable Dividend: Whilst dividend payments have been stable, BDAB.F has been paying a dividend for less than 10 years.

Information is not available.


Current Payout to Shareholders

Information is not available.


Future Payout to Shareholders

Information is not available.


Next Steps

Management

What is the CEO of Boule Diagnostics's salary, the management and board of directors tenure and is there insider trading?

1.9yrs

Average management tenure


CEO

Fredrik Dalborg (46yo)

1.8yrs

Tenure

kr4,372,043

Compensation

Mr. Fredrik Dalborg has been Chief Executive Officer and Group President at Boule Diagnostics AB (publ) since April 01, 2017. Mr. Dalborg served as a Director of Investor Relations and Corporate Finance of ...


CEO Compensation Analysis

Information is not available.

Information is not available.


Management Age and Tenure

1.9yrs

Average Tenure

Information is not available.


Board Age and Tenure

3.5yrs

Average Tenure

58yo

Average Age

Information is not available.


Insider Trading

Information is not available.


Recent Insider Transactions

Buykr3,60228 Sep 19
Christina Rubenhag
EntityIndividual
Role
Chief Financial Officer
Senior VP & CFO
Shares800
Max Pricekr4.50
Buykr10,52621 Aug 19
Christina Rubenhag
EntityIndividual
Role
Chief Financial Officer
Senior VP & CFO
Shares2,500
Max Pricekr4.21
Buykr68,61120 Aug 19
Thomas Eklund
EntityIndividual
Role
Member of the Board of Directors
Director
Shares17,203
Max Pricekr3.99
Buykr11,72316 Aug 19
Karin Dahllöf
EntityIndividual
Role
Member of the Board of Directors
Director
Shares2,900
Max Pricekr4.04
Buykr21,61225 Jun 19
Karin Dahllöf
EntityIndividual
Role
Member of the Board of Directors
Director
Shares3,750
Max Pricekr5.76
Buykr843,22920 Jun 19
Thomas Eklund
EntityIndividual
Role
Member of the Board of Directors
Director
Shares150,000
Max Pricekr5.62
Buykr90,25909 Feb 19
Peter von Ehrenheim
EntityIndividual
Role
Chairman of the Board
Chairman of the Board
Shares14,230
Max Pricekr6.50
Buykr13,16408 Feb 19
Fredrik Dalborg
EntityIndividual
Role
Chief Executive Officer
CEO & Group President
Shares2,000
Max Pricekr6.58

Ownership Breakdown


Management Team

  • Fredrik Dalborg (46yo)

    CEO & Group President

    • Tenure: 1.8yrs
    • Compensation: kr4.37m
  • Hans Johansson

    Senior Vice President of Production

    • Tenure: 0yrs
  • Christina Rubenhag

    Senior VP & CFO

    • Tenure: 1.3yrs
  • Karen Bornstein

    Head of Marketing

    • Tenure: 15yrs
  • Mike Eliott

    Head of Development - Reagents & Consumables

    • Tenure: 27yrs
  • Christina Hugosson (55yo)

    Head of Development - Instruments & Systems

    • Tenure: 12yrs
  • Debbie Herrera

    Senior Vice President of Quality & Regulatory

    • Tenure: 2yrs
  • Fredrik Ekdahl

    Senior Vice President of R&D

    • Tenure: 1.6yrs
  • Kiarash Farr

    Senior Vice President of Commercial Operations

    • Tenure: 0.8yrs
  • Eva Ekermann

    Human Resources Manager

    • Tenure: 0yrs

Board Members

  • Jon Risfelt (57yo)

    Director

    • Tenure: 3yrs
    • Compensation: kr200.00k
  • Peter von Ehrenheim (63yo)

    Chairman of the Board

    • Tenure: 3yrs
    • Compensation: kr400.00k
  • Thomas Eklund (51yo)

    Director

    • Tenure: 5yrs
    • Compensation: kr200.00k
  • Karin Dahllöf (59yo)

    Director

    • Tenure: 4yrs
    • Compensation: kr200.00k

Company Information

Boule Diagnostics AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Boule Diagnostics AB (publ)
  • Ticker: BDAB.F
  • Exchange: OTCPK
  • Founded: 1956
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr1.081b
  • Listing Market Cap: kr119.433m
  • Shares outstanding: 19.42m
  • Website: https://www.boule.com

Number of Employees


Location

  • Boule Diagnostics AB (publ)
  • Domnarvsgatan 4
  • Spånga
  • Stockholm County
  • 163 53
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BOULOM (OMX Nordic Exchange Stockholm)YesCommon SharesSESEKJun 2011
BDAB.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJun 2011
BOULSBATS-CHIXE (BATS 'Chi-X Europe')YesCommon SharesGBSEKJun 2011

Biography

Boule Diagnostics AB (publ), a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. It provides hematology analyzers, reagents, blood controls ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/01/28 00:45
End of Day Share Price2018/10/30 00:00
Earnings2018/09/30
Annual Earnings2017/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.